Bafetinib
Product Specifications
CAS Number
859212-16-1
Target
Autophagy|||Apoptosis|||Src|||Bcr-Abl
Related Pathways
Autophagy|||Tyrosine Kinase/Adaptors|||Cytoskeletal Signaling|||Angiogenesis|||Apoptosis
Purity
0.9968
Bioactivity
Bafetinib (INNO-406) (INNO-406) is an effective and specific dual Bcr-Abl/Lyn inhibitor (IC50: 5.8/19 nM), and no inhibition of the phosphorylation of the T315I mutant and less effective to c-Kit and PDGFR.
Smiles
CN(C)[C@H]1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cncnc3)c2)C1
Molecular Formula
C30H31F3N8O
Molecular Weight
576.62
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1031569-01 0.02 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 5b Lysine--tRNA ligase (lysS)
Ask
View Details 
MBS1031569-02 0.02 mg (Yeast)
Recombinant Actinobacillus pleuropneumoniae serotype 5b Lysine--tRNA ligase (lysS)
Ask
View Details MBS1031569-03 0.1 mg (E-Coli)
Recombinant Actinobacillus pleuropneumoniae serotype 5b Lysine--tRNA ligase (lysS)
Ask
View Details MBS1031569-04 0.1 mg (Yeast)
Recombinant Actinobacillus pleuropneumoniae serotype 5b Lysine--tRNA ligase (lysS)
Ask
View Details 
MBS1031569-05 0.02 mg (Baculovirus)
Recombinant Actinobacillus pleuropneumoniae serotype 5b Lysine--tRNA ligase (lysS)
Ask
View Details 
MBS1031569-06 0.02 mg (Mammalian-Cell)
Recombinant Actinobacillus pleuropneumoniae serotype 5b Lysine--tRNA ligase (lysS)
Ask
View Details